DARMSTADT, GERMANY

Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

– Adds to Merck’s lipid manufacturing expertise, providing an integrated offering across mRNA value chain – AmpTec’s differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA manufacturing – Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio Merck, a […]

thaipr.net

7 ม.ค. 64

Merck Expands Life Science Production Capacities in the United States

– Expansions to significantly increase capacity by end of 2021 to meet unprecedented demand – Combined expansion of Danvers, Massachusetts, and Jaffrey, New Hampshire, USA facilities to create nearly 700 new positions – Business sector’s announced 2020 investments total more than € 350 million Merck, a leading science and technology company, today announced the broadening […]

thaipr.net

8 ธ.ค. 63

European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition factor gene (MET) exon 14 (METex14) skipping alterations. With this validation, the application is complete, and […]

thaipr.net

27 พ.ย. 63
1 2

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.